Chronic hepatitis delta cirrhosis cured by adapting PEG-IFNα-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss.
- DOI
- 10.1016/j.clinre.2023.102148
- Published
- 2023 Aug
- Container
- Clinics and research in hepatology and gastroenterology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clinre.2023.102148,
title = {Chronic hepatitis delta cirrhosis cured by adapting PEG-IFNα-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss.},
author = {Yaici L and Gatouillat G and Andreoletti L and N'Guyen Y and Hentzien M and Gordien E and Bani-Sadr F},
year = {2023},
journal = {Clinics and research in hepatology and gastroenterology},
doi = {10.1016/j.clinre.2023.102148},
url = {https://doi.org/10.1016/j.clinre.2023.102148}
}RIS
TY - JOUR TI - Chronic hepatitis delta cirrhosis cured by adapting PEG-IFNα-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss. AU - Yaici L AU - Gatouillat G AU - Andreoletti L AU - N'Guyen Y AU - Hentzien M AU - Gordien E AU - Bani-Sadr F PY - 2023 JO - Clinics and research in hepatology and gastroenterology DO - 10.1016/j.clinre.2023.102148 UR - https://doi.org/10.1016/j.clinre.2023.102148 ER -
APA
L, Y., G, G., L, A., Y, N., M, H., E, G., & F, B. (2023). Chronic hepatitis delta cirrhosis cured by adapting PEG-IFNα-2a + tenofovir disoproxil fumarate treatment duration until HBsAg loss.. Clinics and research in hepatology and gastroenterology. https://doi.org/10.1016/j.clinre.2023.102148